Drug-Coated Stent Inspection
Closing the Gap Between Coating and Performance
In stent manufacturing, drug coating is often viewed as the stage where therapeutic value is introduced. However, the real challenge lies not just in applying the coating, but in ensuring that the coated stent maintains its structural integrity and performs exactly as intended. This is where inspection becomes a critical link between process and outcome.
Drug-coated stents combine mechanical precision with pharmacological function. While coating processes are designed to deliver uniform drug distribution, they can also introduce subtle variations in geometry or surface behaviour. These variations are not always visible, yet they can influence how the stent expands, how the drug is released, and ultimately how it performs inside the body.
Why Post-Coating Inspection Is Different
Unlike pre-coating inspection, evaluating a coated stent requires a more refined approach. The inspection process must ensure accuracy without disturbing the coating layer. Contact-based methods risk damaging the surface, while visual inspection alone cannot provide the level of detail required for modern stent designs.
Manufacturers are therefore shifting toward inspection methods that are both non-invasive and data-driven, allowing them to validate the stent in its final, coated condition.
From Coating Process to Measurable Validation
Inspection after drug coating is no longer just about defect detection—it is about confirming that the entire process has delivered a consistent and reliable product. By analysing parameters such as symmetry, alignment, and dimensional stability, manufacturers can verify that coating has not introduced unintended deviations.
This approach transforms inspection into a tool for process validation. Instead of relying on assumptions about coating performance, manufacturers gain measurable evidence that supports both quality assurance and regulatory requirements.
Enhancing Process Control and Consistency
One of the key advantages of post-coating inspection is the ability to identify trends. If certain variations appear consistently, they may indicate issues in coating parameters, material behaviour, or upstream processes. Addressing these insights early helps reduce variability, improve yield, and ensure more stable production.
As production scales and product designs become more complex, this level of control becomes essential. Inspection systems must not only detect defects but also provide actionable data that supports continuous improvement.
Where StentSpect DC Fits In
StentSpect DC is designed specifically for the inspection of drug-coated stents, enabling non-contact evaluation of critical parameters without affecting the coating layer. By combining precision measurement with automated analysis, it provides repeatable, objective results that support both process control and quality validation.